Please use this identifier to cite or link to this item:
|Title:||Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity||Authors:||Sottoriva, Andrea
Verhoeff, Joost J. C.
Medema, Jan Paul
Sloot, Peter M. A.
|Issue Date:||2010||Source:||Sottoriva, A., Verhoeff, J. J. C., Borovski, T., McWeeney, S. K., Naumov, L., Medema, J. P., et al. (2010). Cancer Stem Cell Tumor Model Reveals Invasive Morphology and Increased Phenotypical Heterogeneity. Cancer Research, 70(1), 46-56.||Series/Report no.:||Cancer Research||Abstract:||The recently developed concept of cancer stem cells (CSC) sheds new light on various aspects of tumor growth and progression. Here, we present a mathematical model of malignancies to investigate how a hierarchical organized cancer cell population affects the fundamental properties of solid malignancies. We establish that tumors modeled in a CSC context more faithfully resemble human malignancies and show invasive behavior, whereas tumors without a CSC hierarchy do not. These findings are corroborated by in vitro studies. In addition, we provide evidence that the CSC model is accompanied by highly altered evolutionary dynamics compared with the ones predicted to exist in a stochastic, nonhierarchical tumor model. Our main findings indicate that the CSC model allows for significantly higher tumor heterogeneity, which may affect therapy resistance. Moreover, we show that therapy which fails to target the CSC population is not only unsuccessful in curing the patient, but also promotes malignant features in the recurring tumor. These include rapid expansion, increased invasion, and enhanced heterogeneity.||URI:||https://hdl.handle.net/10356/96024
|DOI:||http://dx.doi.org/10.1158/0008-5472.CAN-09-3663||Rights:||© 2010 American Association for Cancer Research.||Fulltext Permission:||none||Fulltext Availability:||No Fulltext|
|Appears in Collections:||SCSE Journal Articles|
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.